Department of Plastic Surgery and Reconstructive Surgery,
© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Lymphedema is a chronic and progressive pathological state of tissue swelling caused by congenital or acquired lymphatic abnormality. History, physical and laboratory examinations could help to diagnosis > 90% lymphedema patients. Early stage lymphedema could be challenging to diagnose. The aim of this review is to provide an objective appraisal of current diagnostic methods, such as lymphoscintigraphy, lympho-fluoroscopies, lymphangiography and etc. focusing on their respective advantages and weaknesses, and hopefully shed some lights on developing a practical diagnosis modality beneficial to early detection and clinical decision making of lymphedema.
Lymphedema, diagnosis, lymphoscintigraphy, magnetic resonance lymphangiography, indocyanine green, tissue dielectric constant, bioelectrical impedance spectroscopy
Lymphedema is a pathological state of tissue swelling due to excess protein-rich fluid accumulation in the interstitial space. The equilibrium between load of lymph fluid and transport capacity of the lymphatics is almost invariably disturbed by either congenital dysplasia of the lymphatic system (primary lymphedema) or acquired impairment of the lymphatic drainage (secondary lymphedema). Contrary to all expectations, lymphedema has been reported to affect approximately 300 million people worldwide. The incidence of primary lymphedema is 1 in 100,000 individuals with that of secondary one being is 1 in 1000 individuals. Its global impact may even be severely underestimated resulting from various diagnosis methods and common neglect of the disease. As a chronic and progressive condition, lymphedema, if left untreated, could give rise to disabling physical and psychosocial complications in the long run. Currently, the attention on lymphedema is far from enough resulting in delayed initial evaluation and treatment and poor prognosis. There is no existing cure for lymphedema and current therapies mainly focus on limiting progression and preventing severe complications. Early intervention is proved to be the root of improved prognosis thus highlighting the significance of early detection. Various new and effective diagnostic methods emerge over the years but there are still no standard guidelines for lymphedema diagnosis, let alone early detection. The aim of this review is to provide an objective appraisal of current diagnostic methods, focusing on their respective advantages and weaknesses, and hopefully shed some lights on developing a practical diagnosis modality beneficial to early detection and clinical decision making of lymphedema.
For suspected lymphedema patients, history and manifestations are invaluable and indispensable. The onset of swelling could be diagnostic for lymphedema. Extremity swelling present for less than 3 months or forms soon after lymphatic injury is not consistent with lymphedema. It’s very common to see pediatrics-onset in primary lymphedema, boys’ present in infancy and girls’ during adolescence. For secondary lymphedema, travels to parasite-endemic area (filariasis), obesity (BMI > 50), radical cancer treatment for breast, gynaecological, head and neck cancer (nodes dissection, chemotherapy and radiotherapy), nodes biopsy can be crucial risk factors, while family history is more frequently seen in primary lymphedema. Docetaxel-based chemotherapy has been shown to increase the incidence of breast cancer treatment related lymphedema.
Complaints of extremity heaviness and fatigue could be the main manifestation of early stage lymphedema. As it progresses, visible limb swelling and enlargement of circumference take place. Different tools are utilized to assess extremity volume/circumference. Tape measurement is applying a flexible and non-stretch tape to assess the girth of edematous limb at certain points following different protocols. Absolute values are usually converted into volumes using respective mathematical formulae visualizing the limb as a series of truncated cones, cylinders and trapezoidal solids. Absolute excess volume (affected limb-unaffected limb), excess volume in percent [(affected limb-unaffected limb)/unaffected limb × 100], relative value in percent (affected limb/unaffected limb × 100) and affected leg volume divided by BMI are useful indices in unilateral lymphedema diagnosis. Girth assessment is the most fundamental and commonly used method for its feasibility and economical advantages but is limited by its high inter- and intra-observer variability and poor reproducibility. In water plethysmography, the amount of water displaced after immersing the limb of interest into a water tank equals the extremity volume. It’s considered as the criterion standard for lymphedema diagnosis but also deemed impractical in clinical setting for its cumbersome set-up, patient-unfriendly measurement protocol and extra contraindications concerning water. Extremity volume difference > 10%, volume change > 200 mL or circumference change > 2 cm at one certain point are deemed diagnostic, though there are still no standardized cut-off points among health practioners.
A square frame emitting infrared lights is used in perometry. As the frame moves along the limb, information of the interrupted lights is converted into coordinates to reconstruct a 3D model and automatically calculate the volume. Similarly, three-dimensional imaging systems such as the VECTRA XT surface photo imaging system (Canfield Imaging Systems, Fairfield, NJ) are developed to capture 360° digital image data of the edematous extremity. Absolute values or image color change by photographs contrast presents volume changes before and after treatment, thus making VECTRA valuable in both diagnosis and monitoring. VECTRA, as a relatively new technique provides high resolution images and might be applied to the whole body, facial and pubic region included[7,8]. However, both three-dimensional photography and perometry are costly and not obtainable in every clinic.
As edema persists, difficulty of fitting clothing, joint dysfunction and musculoskeletal agony may appear. Characteristic skin changes including peau d’orange (pitted or dimpled skin texture), Kaposi-Stemmer sign (the inability to pinch the fold of skin at the base of the second toe) and squared off appearance of toes assists to identify lymphedema. Hyperkeratosis and fibrosis with verruca and nodules usually indicate advanced stages. Lymphedematous extremity is prone to recurrent infection, cellulitis lymphangitis, lymphorrhea and skin ulceration. Angiosarcoma that initially presents itself as red-purple nodules with/without satellite lesions is a rare but lethal complication.
Laboratory examinations such as routine blood test, thyroid function or urinalysis are in need to rule out other causes of edema, including renal, heart or hepatic failure etc. Though thorough history, physical and laboratory examinations could help to diagnosis > 90% lymphedema patients, lymphedema in early stages could be surprisingly challenging to diagnose, making assistant methods necessary for early detection and confirmation.
It’s widely accepted that lymphedema progresses through 4 stages. Stage 0 is the subclinical stage where swelling is absent but with impaired lymph transport and possible complaints of discomfort or heaviness. Stage 1 is spontaneously reversible edema that subsides with limb elevation, while the swelling of stage 2 could not be relieved by elevation. Stage 3, also known as lymphostatic elephantiasis, describes nonpitting edema, fibrosis, hyperkeratosis and the aforementioned complications[2,9].
Lymphoscintigraphy has been regarded as the gold standard for the diagnosis of lymphedema since its first introduction. It involves the intradermal or subcutaneous injection into the hand or feet of radiolabeled particles usually under the size of 100 nmol/L, such as 99m Tc (Technetium) human serum albumin nanocolloid, 99m Tc sulfur colloid and 99m Tc albumin colloid. Gamma camera systems are applied to capture the radiopharmaceutical emission as it is taken up and transported by the lymphatic vasculature. Lymphoscintigraphy demonstrates the lymphatic vessels efferent from the injected sites and lymph nodes along the pathway. Typical abnormalities include formation of collateral lymphatic channels, asymmetric visualization of lymphatic channels, delayed or asymmetric node uptake, absent or delayed visualization of lymph nodes, unusual visualization of the popliteal or antecubital lymph nodes (compensatory mechanism involving deeper lymph pathways)[10,11].
Dermal backflow, accumulation of tracer outside the main lymph routes and in cutaneous lymphatices, and lymphangiectasia are considered major diagnostic findings for lymphedema. Other than morphologic-qualitative information, lymphoscintigraphy provides us with quantitative information of the lymphatics. Commonly used parameters consist of TAT (tracer appearance time, the time from injection to the appearance of the tracer in the inguinal or axillary lymph nodes, normally < 10 min) and TI (Transport Index, normally ranges from 1 to 10).
Hassanein et al. in their study including 227 patients (454 limbs) suggested the sensitivity and the specificity of lymphoscintigraphy for lymphedema is 96% and 100% respectively. Early primary lymphedema may result in false-negative lymphoscintigrams so repeat lymphoscintigraphy is recommended. The recently developed Taiwan Lymphoscintigraphy Staging might provide a new angle of assessing the severity of lymphedema. Lymphoscintigraphy is also valuable in early detection and treatment selection, especially surgical planning as it allows to seek out possible functional lymphatic vessels for vessels to use for lymphatic-venous anastomosis (LVA). Compared to lymphangiography, the tracer used in lymphoscintigraphy rarely causes the allergy and pulmonary embolism, so it’s safe and relatively minimally invasive.
Despite its distinct advantages, the protocol of lymphoscintigraphy is poorly standardized, such as the amount of the labeled particles and the injection volume, which substantially affect the quantitative parameters and hinders comparisons between studies. Injection site is also one of the major debates. Tartaglione et al. suggested intermetatarsal or intermetacarpal spaces injection, as compared with traditional interdigital area, results in rapid uptake of tracers, improved imaging quality and reduced examination time (average time 4 h reduced to < 1 h). Though combined with computed tomography (CT) or SPECT, spatial resolution of lymphoscintigraphy images improves, it is still far from enough and limited for detection of the small lymphatic vessel leaks. Owing to discontinuous image acquisition, diagnostic events could happen between acquisition points and be missed. Irradiation is the frequent concern raised in many studies. Though, no cutaneous radio-necrosis has been reported, extra precautions still needs to be taken concerning pregnant and breastfeeding women.
Lympho-fluoroscopies applies fluorescent molecules such as indocyanine green (ICG), methylene blue etc. as the imaging agent. ICG lymphography encompasses the subcutaneous injection of ICG, the usual amount being 0.2 mL. Common injection sites include webspaces of the hand or foot, the medial and/or lateral border of the Achilles tendon, the ulnar side of the palmaris longus tendon at the wrist level[15,16]. Different near-infrared camera devices are used 12-24 h after injection to record the light emitted by ICG thus visualizing the collecting lymphatic vessels. Linear pattern represents normal or mildly impeded lymphatic collector function, while dermal backflow pattern including splash, stardust of diffuse pattern indicates lymphedema. ICG lymphography is deemed to be the most valuable tool for superficial lymphatics imaging. Compared to lymphoscintigraphy, ICG lymphography is not irradiating with similar sensitivity and specificity (97% and 92%) but superior resolution and at lower cost. Yamamoto et al. suggested in their study when utilizing ICG lymphography to select optimal sites for LVA, the overall lymphatic vessel detection rate, confirmed by intraoperative findings, is 96.1%. ICG lymphography can be used for early recognition of lymphedema, as some patients without symptoms can still show abnormal images. However, ICG lymphography is time consuming and operator dependent. It’s unable to observe lymphatics where the tissue is thicker than 2 cm, limiting its possible application in the trunk area and obese patients. Quantification might be more difficult compared to lymphoscintigraphy due to the injection of free ICG (the amount, the concentration etc.). Potential toxicity in the lymphatic vessels and its persistence after subcutaneous injection raise some concern because of the lack of studies about its side effects.
The fluorescein used in fluorescence microlymphography (FML) is fluorescein isothiocyanate (FITC)-labeled dextran. 0.1 mL of 25% FITC-labeled dextran solution dissolved by 0.9% sodium or potassium chloride solution is injected into the intradermal layer of the forearm, toes or even the face with a tuberculin syringe and a 25-gauge needle. Under A fluorescent light microscope, a network of lymphatic becomes visible as the dye spreads through the lymphatics. 10 min after injection, the distance between the border of the injection site and the furthest visible lymphatics is measured in four directions. The maximum extension distance in healthy limbs should not exceed 14 mm. Sensitivity and specificity for the 14 mm cut off level is 91.4% and 85.7%. Sensitivity was higher in the secondary vs. primary lymphedema. FML could be used near venous ulcers or indurated skin and rarely cause allergy or other major side effects. However, deeper lymphatic vessels cannot be visualized by FML.
Lymphangiography applies various contrast medium and imaging systems to depict lymphatic structures. In direct contrast x-ray lymphangiography, liposoluble contrast medium, such as iodine is directly injected into the lymphatic vessel dyed by methylene blue. It has been abandoned due to its traumatic nature, technical complexity, poor repeatability and unacceptable contrast complications. Based on the uptake of water-soluble non-ionic contrast agents by lymphatics, indirect lymphangiography avoids direct administration of peripheral lymphatic vessels and has less complications, which is considered to be the best way to differentiate between lipedema and lymphedema.
Magnetic resonance lymphangiography (MRL) involves the subcutaneous/intradermal injection of gadolinium-based MR contrast agents, such as gadobenate dimeglumine, gadoterate meglumine etc. into the 4 interdigital web spaces of the hand or foot, with 1% lidocaine as anesthetic. Recommended contrast volume is 1 ml for each site. A 3D heavily T2-weighted sequence or a 3D steady-state free precession balanced sequence is performed to assess the distribution and extent of edema before injection. Then a fat-suppressed T1-weighted 3D spoiled gradient-echo (SPGR) is used for the lymphatic visualization before and after injection. The number of phase acquisitions and interval varies[22-24]. A 3D workstation with multiplanar reformations, maximum intensity projection reconstructions and the 3D cursor facilitates image analysis. MRL depicts lymphatic channels, lymph nodes and drainage pattern with supplemental information including fat deposition, muscle compartments and limb volume. Bae et al. and Neligan et al. suggested excellent correlation of MRL with lymphoscintigraphy and ICG lymphography respectively. MRL allows for early recognition, full assessment of lymphedema status and surgical planning especially LVA. Compared to lymphoscintigraphy and ICG lymphography, it is free of radiation and depicts deeper lymphatic channels with higher resolution. Though an extra MR venogram or intravenous administration of Ferumoxytol can help differentiate lymphatic vessels from veins, venous contamination could be a major obstacle in image interpretation. Furthermore, MRL is costly and potentially patient-unfriendly, because it requires patients to stay in the prone or supine position for up to 2 h (the examination duration).
Tissue dielectric constant (TDC) is proven to be proportional to local skin-to-fat water content. The Moisture Meter D or its compact version transmits an 300 MHz electromagnetic wave into the tissue and displays absolute TDC values or a percentage of local tissue water, after automatically processing reflected signal. It takes no more than 10 s for each measurement point. TDC ratio (TDC affected/TDC unaffected) > 1.26 is considered suggestive of lymphedema by some. It can be applied in virtually any areas, midline body regions included, for post-treatment monitoring and early detection. However, TDC is influenced by skin thickness, gender, age, body mass index or race, thus comparison between groups should be dealt with caution and diagnostic threshold is still debatable. In a study by Bakar et al. specificity was 94% with only 65% sensitivity.
Bioelectrical impedance spectroscopy (BIS) utilizes a low frequency current to measure electrical resistance (R0) of local tissue, which inversely proportional to the volume of extracellular fluid volume. For unilateral lymphoedema, the index R0unaffected/ R0affected is commonly used, the larger the ratio the greater the differences in excess extracellular fluid between limbs. Diagnostic cut-off values varies for non/dominant limbs due to natural asymmetry. The Ri/R0 ratio is the widely accepted BIS index for bilateral lymphoedema, which Ri means the resistance of the unaffected body region with similar tissue compositon as the region of interest. BIS examination only takes a few seconds and rarely causes adverse effects. It is uninfluenced by BMI and reliable in predicting onset up to 10 months prior to clinical manifestation[29,30]. Sensitivity and specificity for BIS were 64% and 100%,respectively. However BIS’s less sensitive in diagnosing fibrotic lymphedema and breast or trunk measurement is limited. Extra caution should be taken when it comes to patients with pregnancy, cardiac pacemaker or other implanted medical devices.
CT and magnetic resonance imaging can detect the characteristic honeycomb pattern and the thickening of the subcutis in lymphedema. Ultrasonography rules out edema caused by venous thrombosis or reflux disease. Furthermore, high resolution ultrasonography helps assess central lymphatic channel, such as thoracic duct, the diameter of which is proven to significantly decrease in lymphedema. We retrospectively analyzed the data of all patients with lymphedema treated in our Medical College Hospital, Department of Lymphedema Treatment Center from September 2015 to January 2017. Patients who had received ultrasound of the thoracic duct were included. A total of 14 patients with lower extremity lymphedema were included. All 14 patients who underwent thoracic duct ultrasonography without lower limb arterial or venous thrombosis met the conditions. There were 5 men and 9 women, aged 15-70 years. All 14 patients had lymphedema in the lower extremities: 5 with left lower extremity lymphedema, 6 with right lower extremity lymphedema, and 3 with both lower extremity lymphedema. Of the 14 patients with lymphedema examined with ultrasound, 6 had a normal thoracic duct diameter and 8 had an abnormal thoracic duct diameter. Ultrasound analysis of the thoracic duct showed that the average inner diameter of the thoracic duct was 2.21 ± 0.15 mm in the six patients with a normal TD and 1.99 ± 0.33 mm in the patients with an abnormal thoracic duct.
Positron emission tomography (PET) lymphangiography with 68Ga-labeled NOTA (1,4,7-triazacyclononane-N,N’,N’ ’-triacetic acid) with truncated Evans blue (NEB) (68Ga-NEB PET) allows for rapid visualization of lymphatic vessels. Long et al. suggested 68Ga-NEB PET combined with MRL shows significant advantages over 99mTc-SC lymphoscintigraphy with MRL in microsurgery preoperative evaluation.
FOXC2, GJC2, CCNE1, SOX18 and FLT4 gene mutations have been known to be related to primary lymphedema, while GJA4, GJC2 and HGF/MET mutations correlate with secondary lymphedema. As genomic medicine develops, genetic screening for patients at risk might assist in early detection of lymphedema for the foreseeable future.
Since each diagnostic technique has its own pros and cons [Table 1], there’s no consensus on how to properly diagnose lymphedema. Adjusting to patients’ conditions and clinic facilities, practitioners should choose and combine these diagnostic tools flexibly. Figure 1 demonstrates a potential diagnostic algorithm for lymphedema recommended by the authors.
Comparison of different diagnostic techniques
|Sensitivity||Specificity||Advantages||Limitations||Current clinical use|
|Tape measurement||/||/||Easy to conduct||High inter-/intra-observer variability
|Water plethysmography||/||/||The most accurate measurement of limb volume||Cumbersome set-up
Complex measurement protocol
|3D photography||/||/||3D reconstruction image of limb
|High cost||Therapeutic monitoring
|Lymphoscintigraphy||96%||100%||Morphologic-qualitative and quantitative assessment of lymphatics||Irradiation
Poorly standardized protocol
|ICG lymphography||97%||92%||Valuable superficial lymphatics imaging
|Time consuming (12-24 h)
Limited to superficial lymphatics
|FML||91.4%||85.7%||Time saving (10 min)
Applicable to any body regions
|Limited to superficial lymphatics||Diagnosis|
|MRL||/||/||Full assessment of lymphatics and soft tissue
Time consuming (2 h)
|TDC Measurements||65%||94%||Time saving
Applicable to any body regions
|Lack of diagnostic threshold due to population variation||Early diagnosis|
(a few seconds)
Uninfluenced by BMI
|Reduced sensitivity in late stage lymphedema||Early diagnosis|
|Ultrasonography||/||/||Central lymphatic channel assessment
Ruling out venous cause
|Limited measurement range||Supplementary assessment|
|PET lymphangiography||/||/||Rapid visualization of lymphatics||/||/|
|Genetic screening||/||/||Early detection||/||/|
Conceived the structure of the review: Liang ZY
Wrote and revised the paper: Liang ZY, Long X, Yu NZ, Huang JZ
Read and approved the manuscript: Liang ZY, Long X, Yu NZ, Huang JZAvailability of data and materials
Not applicable.Financial support and sponsorship
None.Conflicts of interest
Long X is a first-author in one of the referenced papers; Long X, Yu NZ and Huang JZ are co-authors in one of the referenced papers.Ethical approval and consent to participate
Not applicable.Consent for publication
© The Author(s) 2019.
1. Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol 2017;77:1009-20.DOIPubMed
2. Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg 2018;32:12-6.DOIPubMedPMC
3. Keeley V. Advances in understanding and management of lymphoedema (cancer, primary). Curr Opin Support Palliat Care 2017;11:355-60.DOIPubMed
4. Hidding JT, Viehoff PB, Beurskens CH, van Laarhoven HW, Nijhuis-van der Sanden MW, et al. Measurement Properties of Instruments for Measuring of Lymphedema: Systematic Review. Phys Ther 2016;96:1965-81.DOIPubMed
5. Bernas M, Thiadens SRJ, Smoot B, Armer JM, Stewart P, et al. Lymphedema following cancer therapy: overview and options. Clin Exp Metastasis 2018;35:547-51.DOIPubMed
6. Tierney S, Aslam M, Rennie K, Grace P. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg 1996;12:412-7.DOIPubMed
7. Tokumoto H, Akita S, Kuriyama M, Mitsukawa N. Utilization of three-dimensional photography (VECTRA) for the evaluation of lower limb lymphedema in patients following lymphovenous anastomosis. Lymphat Res Biol 2018; doi: 10.1089/lrb.2017.0058.DOIPubMed
8. Landau MJ, Kim JS, Gould DJ, Patel KM. Vectra 3D imaging for quantitative volumetric analysis of the upper limb: a feasibility study for tracking outcomes of lymphedema treatment. Plast Reconstr Surg 2018;141:80e-4.DOIPubMed
9. Grada AA, Phillips TJ. Lymphedema: diagnostic workup and management. J Am Acad Dermatol 2017;77:995-1006.DOIPubMed
10. Keo HH, Gretener SB, Staub D. Clinical and diagnostic aspects of lymphedema. Vasa 2017;46:255-61.DOIPubMed
11. Tartaglione G, Visconti G, Bartoletti R, Gentileschi S, Salgarello M, et al. Stress lymphoscintigraphy for early detection and management of secondary limb lymphedema. Clin Nucl Med 2018;43:155-61.DOIPubMed
12. Hassanein AH, Maclellan RA, Grant FD, Greene AK. Diagnostic accuracy of lymphoscintigraphy for lymphedema and analysis of false-negative tests. Plast Reconstr Surg Glob Open 2017;5:e1396.DOIPubMedPMC
13. Cheng MH, Pappalardo M, Lin C, Kuo CF, Lin CY, et al. Validity of the novel taiwan lymphoscintigraphy staging and correlation of cheng lymphedema grading for unilateral extremity lymphedema. Ann Surg 2018;268:513-25.DOIPubMed
14. Yoshida RY, Kariya S, Ha-Kawa S, Tanigawa N. Lymphoscintigraphy for Imaging of the lymphatic flow disorders. Tech Vasc Interv Radiol 2016;19:273-6.DOIPubMed
15. Narushima M, Yamamoto T, Ogata F, Yoshimatsu H, Mihara M, et al. Indocyanine green lymphography findings in limb lymphedema. J Reconstr Microsurg 2016;32:72-9.DOIPubMed
16. Garza RM, Ooi ASH, Falk J, Chang DW. The relationship between clinical and indocyanine green staging in lymphedema. Lymphat Res Biol 2019;17:329-33.DOIPubMed
17. Akita S, Mitsukawa N, Kazama T, Kuriyama M, Kubota Y, et al. Comparison of lymphoscintigraphy and indocyanine green lymphography for the diagnosis of extremity lymphoedema. J Plast Reconstr Aesthet Surg 2013;66:792-8.DOIPubMed
18. Yamamoto T, Yamamoto N, Fuse Y, Narushima M, Koshima I. Optimal sites for supermicrosurgical lymphaticovenular anastomosis: an analysis of lymphatic vessel detection rates on 840 surgical fields in lower extremity lymphedema patients. Plast Reconstr Surg 2018;142:924e-30.DOIPubMed
19. Yamamoto T, Yamamoto N, Ishiura R. Indocyanine green lymphography for lymphedema screening following breast cancer treatment. Plast Reconstr Surg 2017;139:1365e-6.DOIPubMed
20. Keo HH, Husmann M, Groechenig E, Willenberg T, Gretener SB. Diagnostic accuracy of fluorescence microlymphography for detecting limb lymphedema. Eur J Vasc Endovasc Surg 2015;49:474-9.DOIPubMed
21. Keo HH, Schilling M, Buchel R, Grochenig E, Engelberger RP, et al. Sensitivity and specificity of fluorescence microlymphography for detecting lymphedema of the lower extremity. Vasc Med 2013;18:117-21.DOIPubMed
22. Mazzei FG, Gentili F, Guerrini S, Cioffi Squitieri N, Guerrieri D, et al. MR Lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view. Biomed Res Int 2017;2017:2598358.DOIPubMedPMC
23. Mitsumori LM, McDonald ES, Neligan PC, Maki JH. Peripheral magnetic resonance lymphangiography: techniques and applications. Tech Vasc Interv Radiol 2016;19:262-72.DOIPubMed
24. Bae JS, Yoo RE, Choi SH, Park SO, Chang H, et al. Evaluation of lymphedema in upper extremities by MR lymphangiography: Comparison with lymphoscintigraphy. Magn Reson Imaging 2018;49:63-70.DOIPubMed
25. Neligan PC, Kung TA, Maki JH. MR lymphangiography in the treatment of lymphedema. J Surg Oncol 2017;115:18-22.DOIPubMed
26. Koehler LA, Mayrovitz HN. Spatial and temporal variability of upper extremity edema measures after breast cancer surgery. Lymphat Res Biol 2019;17:308-15.DOIPubMedPMC
27. Birkballe S, Jensen MR, Noerregaard S, Gottrup F, Karlsmark T. Can tissue dielectric constant measurement aid in differentiating lymphoedema from lipoedema in women with swollen legs? Br J Dermatol 2014;170:96-102.DOIPubMed
28. Bakar Y, Tugral A, Uyeturk U. Measurement of local tissue water in patients with breast cancer-related lymphedema. Lymphat Res Biol 2018;16:160-4.DOIPubMed
29. Kayiran O, De La Cruz C, Tane K, Soran A. Lymphedema: from diagnosis to treatment. Turk J Surg 2017;33:51-7.DOIPubMedPMC
30. Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001;34:2-11.PubMed
31. Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg 2018;71:1041-50.DOIPubMed
32. Gao C, Yang M, Su N, Li XW, Yang EL, et al. Sonographic assessment of the terminal thoracic duct in patients with lymphedema. Chin Med J (Engl) 2017;130:613-6.DOIPubMedPMC
33. Long X, Zhang J, Zhang D, Gao C, Chi C, et al. Microsurgery guided by sequential preoperative lymphography using (68)Ga-NEB PET and MRI in patients with lower-limb lymphedema. Eur J Nucl Med Mol Imaging 2017;44:1501-10.DOIPubMedPMC
34. Hadizadeh M, Mohaddes Ardebili SM, Salehi M, Young C, Mokarian F, et al. GJA4/Connexin 37 mutations correlate with secondary lymphedema following surgery in breast cancer patients. Biomedicines 2018;6:E23.DOIPubMedPMC
35. Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 2008;6:65-8.DOIPubMedPMC
Liang ZY, Long X, Yu NZ, Huang JZ. Diagnostic workup of lymphedema. Plast Aesthet Res 2019;6:23. http://dx.doi.org/10.20517/2347-9264.2019.33
Xiao-Dan Shi et al., Neuroimmunology and Neuroinflammation, 2020
Lorena Quirico et al., Cancer Drug Resistance, 2020
Hin-Lun Liu et al., Plastic and Aesthetic Research, 2020
Hiroo Suami et al., Plastic and Aesthetic Research, 2019
Partha Pratim Bose et al., Hepatoma Research, 2019
Xiao-Dong Zhang et al., Hepatoma Research, 2019
Paola Guerriero et al., Hepatoma Research, 2019
Faiez N. Hattab et al., Stomatological Disease and Science, 2019
Vladimir Zaichick et al., Journal of Cancer Metastasis and Treatment, 2018
Kazuhiro Nouso et al., Hepatoma Research, 2018